Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors.

Journal of hematology & oncology·2026
Same author

Inequities in enrollment across clinical trial phases and the need for a Spanish perspective.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Immunotherapy and tyrosine kinase inhibitors in chordoma: a real-world data study from a European Reference Network on Rare Adult Solid Cancers member center.

Frontiers in oncology·2026
Same author

Distant Metastasis of Merkel Cell Carcinoma: A Descriptive Study.

Dermatology practical & conceptual·2025

Related Experiment Video

Updated: Apr 21, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K

Leiomyosarcoma: Principles of management.

Juan Martin-Liberal1

  • 1The Royal Marsden Hospital, London, UK.

Intractable & Rare Diseases Research
|October 25, 2014
PubMed
Summary

Soft-tissue sarcomas (STS) and leiomyosarcomas have limited treatment options and poor prognoses. New, histology-specific clinical trials are crucial for improving patient outcomes and guiding personalized treatment decisions.

Area of Science:

  • Medical Oncology
  • Clinical Research
  • Cancer Biology

Background:

  • Soft-tissue sarcomas (STS) encompass over 50 subtypes, often with poor prognoses.
  • Current treatments like doxorubicin and ifosfamide show limited efficacy and survival impact.
  • Leiomyosarcomas, a frequent STS subtype, face challenges due to biological heterogeneity and poor response to systemic therapies.

Purpose of the Study:

  • To highlight the urgent need for novel therapeutic strategies in soft-tissue sarcomas.
  • To address the specific challenges in treating leiomyosarcomas, including their heterogeneity and limited treatment effectiveness.
  • To emphasize the importance of histology-specific clinical trials for advancing STS and leiomyosarcoma treatment.

Main Methods:

  • Review of current treatment landscape for soft-tissue sarcomas and leiomyosarcomas.
Keywords:
Leiomyosarcomachemotherapyhormone treatmentsarcomatargeted therapies

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K
  • Analysis of limitations in existing clinical trial designs for STS.
  • Discussion on the impact of biological heterogeneity on treatment response.
  • Main Results:

    • Existing systemic treatments for STS, including leiomyosarcomas, demonstrate suboptimal response rates and survival benefits.
    • Current evidence-based treatments often lack subtype-specific distinctions, complicating therapeutic decisions.
    • The heterogeneity of leiomyosarcomas poses significant challenges for effective chemotherapy.

    Conclusions:

    • There is a critical need for new treatment options for soft-tissue sarcomas and leiomyosarcomas.
    • Individualized treatment decisions in collaboration with patients are essential.
    • Future clinical trials must be histology-designed to improve treatment efficacy and patient outcomes.